Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CABOTEGRAVIR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00659191
What this trial is testing

A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

Who this might be right for
HIV Infection
GlaxoSmithKline 58
Large-scale testing (Phase 3)Study completedNCT05896761
What this trial is testing

A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 118
Early research (Phase 1)Study completedNCT02354950
What this trial is testing

Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers

Who this might be right for
HIV Infections
ViiV Healthcare 16
Early research (Phase 1)Study completedNCT03422172
What this trial is testing

A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese Men

Who this might be right for
HIV Infections
ViiV Healthcare 48
Not applicableLooking for participantsNCT05044962
What this trial is testing

Kuwa Free! - Live Free!

Who this might be right for
HIV InfectionsContraceptionDrug-drug Interaction
University of Alabama at Birmingham 700
Not applicableNot Yet RecruitingNCT07402044
What this trial is testing

CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)

Who this might be right for
CABOTEGRAVIRLENACAPAVIR
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 50
Early research (Phase 1)Study completedNCT02411435
What this trial is testing

Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 15
Post-approval studies (Phase 4)Study completedNCT06185452
What this trial is testing

Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine

Who this might be right for
HIV-1 Infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 103
Not applicableNot Yet RecruitingNCT05835635
What this trial is testing

Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine

Who this might be right for
Patient SatisfactionPatient PreferenceQuality of Life+1 more
Pontificia Universidad Catolica de Chile 50
Early research (Phase 1)Looking for participantsNCT07672717
What this trial is testing

Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

Who this might be right for
HIVProphylaxisInjectable
Johns Hopkins University 32
Not applicableUnknownNCT05949203
What this trial is testing

Oregon PrEP at Home Study

Who this might be right for
HIV/AIDS
Oregon Health and Science University 125
Not applicableLooking for participantsNCT04979728
What this trial is testing

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots

Who this might be right for
HIV TreatmentHIV Prevention
University of Colorado, Denver 150
Testing effectiveness (Phase 2)Looking for participantsNCT07275606
What this trial is testing

Investigate Cabotegravir for Neonates Exposed to HIV-1

Who this might be right for
HIV Infections
ViiV Healthcare 44
Early research (Phase 1)Study completedNCT01848340
What this trial is testing

Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16
Early research (Phase 1)Study completedNCT02354937
What this trial is testing

Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 16
Not applicableLooking for participantsNCT06868641
What this trial is testing

The TAIL-PrEP Study

Who this might be right for
HIV Infections
Columbia University 30
Not applicableAvailableNCT03462810
What this trial is testing

GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare
Early research (Phase 1)Study completedNCT06033547
What this trial is testing

Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 56
Testing effectiveness (Phase 2)Study completedNCT03639311
What this trial is testing

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Who this might be right for
HIV Infections
ViiV Healthcare 97
Not applicableLooking for participantsNCT05663580
What this trial is testing

Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy

Who this might be right for
HIV Infections
Castagna Antonella 1,500
Next Page